LncRNA SNHG22 promotes gastric cancer progression by regulating the miR-101-3p/e2f2 axis

References

• Sugano K. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29(6):895–905.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Kim YI, Kim YW, Choi IJ, et al. Long-Term survival after endoscopic resection versus surgery in early gastric cancers. Endoscopy. 2015;47(4):293–301.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Oda I, Abe S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19(1):198–205.
   PubMed Web of Science ®Google Scholar
• Miyahara R, Niwa Y, Matsuura T, et al. Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 years. J Gastroenterol Hepatol. 2007;22(9):1435–1442.
   PubMed Web of Science ®Google Scholar
• Song W, Liu YY, Peng JJ, et al. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer. J Gastroenterol. 2016;51(2):119–129.
   PubMed Web of Science ®Google Scholar
• Liu X, Meltzer SJ. Gastric cancer in the era of precision medicine. Cell Mol Gastroenterol Hepatol. 2017;3(3):348–358.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Wei GH, Wang X. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(17):3850–3856.
   PubMed Web of Science ®Google Scholar
• Tang W, Fu K, Sun H, et al. CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer. Mol Cancer. 2018;17(1):137.
   PubMedGoogle Scholar
• Hu S, Zheng Q, Wu H, et al. miR-532 promoted gastric cancer migration and invasion by targeting NKD1. Life Sci. 2017;177:15–19.
   PubMed Web of Science ®Google Scholar
• Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics Proteomics Bioinformatics. 2016;14(1):42–54.
   PubMed Web of Science ®Google Scholar
• Yu H, Rong L. Emerging role of long non-coding RNA in the development of gastric cancer. World J Gastrointest Oncol. 2018;10(9):260–270.
   PubMed Web of Science ®Google Scholar
• Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–1076. DOI:10.1038/nature08975
   PubMed Web of Science ®Google Scholar
• Majem B, Rigau M, Reventos J, et al. Non-Coding RNAs in saliva: emerging biomarkers for molecular diagnostics. Int J Mol Sci. 2015;16(4):8676–8698.
   PubMed Web of Science ®Google Scholar
• Yang ZG, Gao L, Guo XB, et al. Roles of long non-coding RNAs in gastric cancer metastasis. World J Gastroenterol. 2015;21(17):5220–5230.
   PubMed Web of Science ®Google Scholar
• Zhu X, Li Z, Li T, et al. Osthole inhibits the PI3K/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma. Biomed Pharmacother. 2018;102:502–509.
   PubMed Web of Science ®Google Scholar
• Li ZW, Zhang TY, Yue GJ, et al. Small nucleolar RNA host gene 22 (SNHG22) promotes the progression of esophageal squamous cell carcinoma by miR-429/SESN3 axis. Ann Transl Med. 2020;8(16):1007.
   PubMed Web of Science ®Google Scholar
• Fang X, Zhang J, Li C, et al. Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3. Cancer Cell Int. 2020;20(1):252.
   PubMed Web of Science ®Google Scholar
• Yao J, Wang C, Dong X, et al. lncRNA SNHG22 sponges miR1283p to promote the progression of colorectal cancer by upregulating E2F3. Int J Oncol. 2021;59(3). DOI:10.3892/ijo.2021.5251
   Web of Science ®Google Scholar
• Cui X, Zhang H, Chen T, et al. Long noncoding RNA SNHG22 induces cell migration, invasion, and angiogenesis of gastric cancer cells via microRNA-361-3p/hmga1/wnt/beta-catenin axis. Cancer Manag Res. 2020;12:12867–12883.
   PubMed Web of Science ®Google Scholar
• Zhang PF, Wu J, Luo JH, et al. SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/gal-1 signaling pathway in epithelial ovarian carcinoma. Aging (Albany NY). 2019;11(19):8204–8216.
   PubMedGoogle Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–358.
   PubMed Web of Science ®Google Scholar
• Zhang J, Lou W. A key mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network linked to diagnosis and prognosis of hepatocellular carcinoma. Front Oncol. 2020;10:340.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yu Z, Ma R, et al. lncRNA-Xist/mir-101-3p/klf6/c/ebpalpha axis promotes TAM polarization to regulate cancer cell proliferation and migration. Mol Ther Nucleic Acids. 2021;23:536–551.
   PubMedGoogle Scholar
• Meng X, Sun Y, Liu S, et al. miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5. Oncol Lett. 2021;21(4):282.
   PubMed Web of Science ®Google Scholar
• Du YL, Liang Y, Cao Y, et al. LncRNA XIST promotes migration and invasion of papillary thyroid cancer cell by modulating MiR-101-3p/cldn1 axis. Biochem Genet. 2021;59(2):437–452.
   PubMed Web of Science ®Google Scholar
• Gu Z, You Z, Yang Y, et al. Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways. Bioengineered. 2021;12(1):4719–4735.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu B. miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2. Arch Gynecol Obstet. 2018;297(6):1539–1548.
   PubMed Web of Science ®Google Scholar
• Li L, Shao MY, Zou SC, et al. MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44. J Neurooncol. 2019;141(1):19–30.
   PubMed Web of Science ®Google Scholar
• Moshiri F, Salvi A, Gramantieri L, et al. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget. 2018;9(20):15350–15364. DOI:10.18632/oncotarget.24601
   PubMedGoogle Scholar
• Zeng W, Zhang S, Yang L, et al. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer. BMC Med Genet. 2020;21(1):28.
   PubMed Web of Science ®Google Scholar
• Cao S, Lin L, Xia X, et al. lncRNA SPRY4-IT1 regulates cell proliferation and migration by sponging miR-101-3p and regulating AMPK expression in gastric cancer. Mol Ther Nucleic Acids. 2019;17:455–464.
   PubMedGoogle Scholar
• Wang L, Shen J, Jiang Y. Circ_0027599/phdla1 suppresses gastric cancer progression by sponging miR-101-3p.1. Cell Biosci. 2018;8(1):58.
   PubMedGoogle Scholar
• Wang H, Zhang X, Liu Y, et al. Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2. Oncotarget. 2016;7(24):36577–36589.
   PubMedGoogle Scholar
• Zhou Q, Zhang F, He Z, et al. E2F2/5/8 serve as potential prognostic biomarkers and targets for human ovarian cancer. Front Oncol. 2019;9:161.
   PubMed Web of Science ®Google Scholar
• Lin QY, Wang JQ, Wu LL, et al. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2. Breast Cancer. 2020;27(1):147–158.
   PubMed Web of Science ®Google Scholar
• Yu J, Fang C, Zhang Z, et al. H19 rises in gastric cancer and exerts a tumor-promoting function via miR-138/E2F2 axis. Cancer Manag Res. 2020;12:13033–13042.
   PubMed Web of Science ®Google Scholar